ULBI - Ultralife Corporation

NasdaqGM - NasdaqGM Delayed Price. Currency in USD
Income Statement
Balance Sheet
Cash Flow

Income Statement

All numbers in thousands
Total Revenue82,46076,42766,494
Cost of Revenue57,35253,11147,144
Gross Profit25,10823,31619,350
Operating Expenses
Research Development5,9465,6035,333
Selling General and Administrative15,39914,23315,460
Non Recurring-150150
Total Operating Expenses---
Operating Income or Loss3,7633,330-1,443
Income from Continuing Operations
Total Other Income/Expenses Net8068-141
Earnings Before Interest and Taxes3,8433,398-1,584
Interest Expense263248218
Income Before Tax3,5803,150-1,802
Income Tax Expense98310268
Minority Interest-170-143-114
Net Income From Continuing Ops3,5092,869-2,070
Non-recurring Events
Discontinued Operations---61
Extraordinary Items---
Effect Of Accounting Changes---
Other Items---
Net Income
Net Income3,5092,869-2,116
Preferred Stock And Other Adjustments---
Net Income Applicable To Common Shares3,5092,869-2,116